Printer-Friendly Version (104k, Adobe Acrobat)

Back

1. Belinson JL. 2000. Unpublished.
2. Denny L et al. 2000. Unpublished.
3. Frisch L, FH Milner and DJ Sherris. 1994. Naked-eye inspection of the cervix after acetic acid application may improve the predictive value of negative cytologic screening. Journal of Family Practice 39(5): 457–460.
4. Gaffikin L et al (eds). 1997. Alternatives for Cervical Cancer Screening and Treatment in Low-Resource Settings. Workshop Proceedings (21–22 May). JHPIEGO Corporation: Baltimore, Maryland.
5. IARC Working Group on Evaluation of Cervical Cancer Screening Programmes. 1986. Screening for squamous cervical cancer: Duration of low risk after negative results of cervical cytology and its implication for screening policies. British Medical Journal 293: 659–664.
6. ICPD. 1994. The Cairo conference: A programme of action for reproductive rights? Center for Reproductive Law & Policy: Cairo, Egypt.
7. Jones SB. 1999. Cancer in developing countries: A call to action. Brit Med J 39: 505–508.
8. Judson FN. 1992. Interactions between human papillomavirus and human immunodeficiency virus infections. Scientific Publications 119: 199–207.
9. Kitchener HC and P Symonds. 1999. Detection of cervical intraepithelial neoplasia in developing countries. Lancet 353: 856–857.
10. Lonky NM et al. 1997. Selecting treatments for cervical disease. OBG Management (January): 60–70.
11. Maggwa BN et al. 1993. The relationship between HIV infection and cervical intraepitelial neoplasia among women attending two family planning clinics in Nairobi, Kenya. AIDS May 7(5):733–738.
12. Megevand E et al. 1996. Acetic acid visualization of the cervix: An alternative to cytologic screening. Obstetrics & Gynecology 88: 383–386.
13. Miotti PG et al. 1996. Cervical abnormalities, human papillomavirus, and human immunodeficiency virus infections in women in Malawi. J Infect Dis Mar 173 (3): 714–717.
14. Mitchell MF et al. 1998. A randomized clinical trial of cryotherapy, loop electrosurgical excision and laser vaporization for treatment of squamous intraepithelial lesions of the cervix. Obstet Gynecol 92: 737–744.
15. Montz FJ. 1996. Impact of therapy for cervical intraepithelial neoplasia on fertility. Am J Obstet Gynecol 175: 1129–1136.
16. Nuovo GJ, R Banbury and PT Calayag. 1991. Human papillomavirus types and recurrent cervical warts in immunocompromised women. Modern Pathol 4: 632–635.
17. Ottaviano M and P La Torre. 1982. Examination of the cervix with the naked eye using acetic acid test. American Journal of Obstetrics & Gynecology 143(2): 139–142.
18. Parkin DM and Sankaranarayanan R. 1999. Prevention of cervical cancer in developing countries. Thai Journal of Obstetrics and Gynaecology. 11(Suppl 1):3–20.
19. Pisani P. 1998. Personal communication. Cited in Preventing Cervical Cancer in Low-Resource Settings. Outlook 16(1): 1–8.
20. Sanghvi H. 1994. Cervical cancer screening in Kenya, in Issues in Cervical Cancer: Seeking Alternatives to Cytology. Blumenthal PD et al (eds). Workshop Proceedings (2–4 March). JHPIEGO Corporation: Baltimore, Maryland.
21. Sankaranarayanan R et al. 1997. Visual inspection as a screening test for cervical cancer control in developing countries, in New Developments in Cervical Cancer Screening and Prevention. Franco E and J Monsonego (eds). Blackwell Science Ltd.: Malden, Massachusetts.
22. Sankaranarayanan R et al. 1998. Visual inspection of the uterine cervix after the application of acetic acid in the detection of cervical carcinoma and its precursors. Cancer. 83(10): 2150–2156.
23. Sankaranarayanan R et al. 1999. Visual inspection with acetic acid in the early detection of cervical cancer and precursors. International Journal of Cancer. 80: 161–163.
24. Sankaranarayanan R and P Pisani. 1997. Prevention measures in the third world: Are they practical?, in New Developments in Cervical Cancer Screening and Prevention. Franco E and J Monsonego (eds). Blackwell Science Ltd.: Malden, Massachusetts.
25. Sankaranarayanan R and R Wesley. 2000. Unpublished.
26. Sherris J. 1998. Preventing cervical cancer in low-resource settings. Outlook. 16(1):1–8.
27. Sivanesaratnam V et al. 1999. Problems in management of CIN. Thai Journal of Obstetrics and Gynaecology. 11(Suppl 1):27–30.
28. Slawson DC, JH Bennett, and JM Herman. 1992. Are Papanicolaou smears enough? Acetic acid washes of the cervix as adjunctive therapy: A HARNET Study. The Journal of Family Practice 35(3): 271–277.
29. University of Zimbabwe/JHPIEGO Cervical Cancer Project. 1999.Visual inspection with acetic acid for cervical cancer screening: Test qualities in a primary care setting. Lancet 353: (9156)869–873. University of Zimbabwe: Chirenje ZM, T Chipato, J Kasule, E Ngwalle, S Rusakaniko and R Makunike. JHPIEGO Corporaton: Gaffikin L, P Blumenthal, J McGrath and H Sanghvi.
30. Walboomers JMM et al. 1999. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189(1):12–19.
31. Womak SD et al. 2000. HPV-based cervical cancer in a population at high risk for HIV infection. Int J Cancer 85: 206–210.
32. World Health Organization (WHO). 1986. Control of cancer of the cervix uteri. A WHO meeting. Bulletin of the World Health Organization 64(4): 607–618.
33. Wright T. 1999. Personal communication.